Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


08.10.2018

1 Am J Surg Pathol
1 Biochem Biophys Res Commun
3 Blood
8 Leuk Lymphoma
2 N Engl J Med
1 Oncol Rep
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. KUBOTA T, Sasaki Y, Shiozawa E, Takimoto M, et al
    Age and CD20 Expression are Significant Prognostic Factors in Human Herpes Virus-8-negative Effusion-based Lymphoma.
    Am J Surg Pathol. 2018 Sep 29. doi: 10.1097/PAS.0000000000001168.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. KANG CH, Lee DH, Lee CO, Du Ha J, et al
    Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC).
    Biochem Biophys Res Commun. 2018 Sep 28. pii: S0006-291X(18)32108.
    PubMed     Text format     Abstract available


    Blood

  3. LEMONNIER F, Dupuis J, Sujobert P, Tournillhac O, et al
    Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma.
    Blood. 2018 Oct 2. pii: blood-2018-04-840538. doi: 10.1182/blood-2018-04-840538.
    PubMed     Text format    

  4. MOSKOWITZ CH, Walewski J, Nademanee A, Masszi T, et al
    Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
    Blood. 2018 Sep 28. pii: blood-2018-07-861641. doi: 10.1182/blood-2018-07-861641
    PubMed     Text format     Abstract available

  5. ZIJLSTRA JM, Boellaard R
    Baseline PET as prognostic marker for Hodgkin?
    Blood. 2018;131:3-4.
    PubMed     Text format    


    Leuk Lymphoma

  6. DHEUR MS, Poirel HA, Ameye G, Tilman G, et al
    Characterization of two new high-grade B-cell lymphoma cell lines with MYC and BCL2 rearrangements that are suitable for in vitro drug sensitivity studies.
    Leuk Lymphoma. 2018 Oct 2:1-10. doi: 10.1080/10428194.2018.1508663.
    PubMed     Text format     Abstract available

  7. GOYAL RK, Nagar SP, Kabadi SM, Kaye JA, et al
    Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States.
    Leuk Lymphoma. 2018 Oct 2:1-9. doi: 10.1080/10428194.2018.1509320.
    PubMed     Text format     Abstract available

  8. SHARMAN JP, Forero-Torres A, Costa LJ, Flinn IW, et al
    Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
    Leuk Lymphoma. 2018 Oct 2:1-10. doi: 10.1080/10428194.2018.1515940.
    PubMed     Text format     Abstract available

  9. CHEN YF, Chang CH, Huang ZN, Su YC, et al
    The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma.
    Leuk Lymphoma. 2018 Oct 2:1-11. doi: 10.1080/10428194.2018.1512709.
    PubMed     Text format     Abstract available

  10. LIU YZ, Xue K, Wang BS, Li CY, et al
    The size and depth of lesions measured by endoscopic ultrasonography are novel prognostic factors of primary gastric diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2018 Oct 2:1-6. doi: 10.1080/10428194.2018.1515942.
    PubMed     Text format     Abstract available

  11. BADAR T, Hamadani M, Bachanova V, Maddocks KJ, et al
    Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin.
    Leuk Lymphoma. 2018 Oct 2:1-7. doi: 10.1080/10428194.2018.1515944.
    PubMed     Text format     Abstract available

  12. ANDERSEN MD, Kamper P, d'Amore A, Clausen M, et al
    The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor (dagger).
    Leuk Lymphoma. 2018 Oct 2:1-7. doi: 10.1080/10428194.2018.1515939.
    PubMed     Text format     Abstract available

  13. WU X, Hsu DK, Wang KH, Huang Y, et al
    IL-10 is overexpressed in human cutaneous T-cell lymphoma and is required for maximal tumor growth in a mouse model.
    Leuk Lymphoma. 2018 Oct 2:1-9. doi: 10.1080/10428194.2018.1516037.
    PubMed     Text format     Abstract available


    N Engl J Med

  14. HANDY MARSHALL C, Nahas-Vigon J, Manesh R, Gelber AC, et al
    Just Beneath the Surface.
    N Engl J Med. 2018;379:968-973.
    PubMed     Text format    

  15. TIACCI E, Venanzi A, Ascani S, Marra A, et al
    High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.
    N Engl J Med. 2018;379:981-984.
    PubMed     Text format    


    Oncol Rep

  16. NIU X, Ji H, Wang Y, Hu S, et al
    Systemic immune response associated with radiation therapy in Bcell nonHodgkin's lymphoma of Waldeyer's ring.
    Oncol Rep. 2018 Sep 28. doi: 10.3892/or.2018.6748.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. POLLOCK SB, Hu A, Mou Y, Martinko AJ, et al
    Highly multiplexed and quantitative cell-surface protein profiling using genetically barcoded antibodies.
    Proc Natl Acad Sci U S A. 2018;115:2836-2841.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: